Your shopping cart is currently empty

KRAS-IN-51 (Compound 597a) is a KRas G12V inhibitor with an IC50 of 2.9 nM for KRas G12V. It has KD values of 17 nM at 20°C and 68 nM at 37°C. KRAS-IN-51 inhibits the phosphorylation of pERK and exhibits antiproliferative activity against SW620 and MIAPaCa-2 cell lines. This compound is applicable for research in colorectal cancer and pancreatic cancer.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | KRAS-IN-51 (Compound 597a) is a KRas G12V inhibitor with an IC50 of 2.9 nM for KRas G12V. It has KD values of 17 nM at 20°C and 68 nM at 37°C. KRAS-IN-51 inhibits the phosphorylation of pERK and exhibits antiproliferative activity against SW620 and MIAPaCa-2 cell lines. This compound is applicable for research in colorectal cancer and pancreatic cancer. |
| Targets&IC50 | KRas (G12V):2.9 nM |
| Molecular Weight | 562.69 |
| Formula | C31H39FN6O3 |
| Cas No. | 3076211-50-9 |
| Smiles | C(#N)C1=C2[C@@]3(CC=4C(CO3)=C(N=C(OC[C@@]56N(C[C@H](F)C5)CCC6)N4)N7[C@](CO)(C)CC7)CC[C@H](C)C2=CC=C1N |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.